4.7 Article

Risk of acute kidney injury in patients who undergo coronary angiography and cardiac surgery in close succession

Journal

EUROPEAN HEART JOURNAL
Volume 33, Issue 16, Pages 2065-2070

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/eurheartj/ehr493

Keywords

Acute kidney injury; Surgery complications; Coronary angiogram; Cardiac surgery; Outcome

Ask authors/readers for more resources

Cardiac surgery and coronary angiography are both associated with risk of acute kidney injury (AKI). We hypothesized that the risk of post-operative AKI increases when coronary angiogram and cardiac surgery are performed in close succession, without sufficient time for recovery from the adverse effects of intravenous contrast. We included 2133 consecutive patients who underwent cardiac surgery at the Minneapolis Veterans Administration Medical Center from 2004 to 2010. Acute kidney injury was defined by the AKI network and the Risk, Injury, Failure, Loss, End-stage (RIFLE) criteria. Patients were 66 10 years old. Mean pre-operative creatinine and estimated glomerular filtration rate were 1.1 0.4 mg/dL and 75 22 mL/min/1.73 m(2), respectively. Cardiac surgery was performed 14 days (range 0235) after coronary angiography. Acute kidney injury occurred in 680 (32) patients per AKI network, 390 (18) patients per RIFLE risk, and 111 (5) patients per RIFLE injury criteria. Age, body mass index, diabetes mellitus, New York Heart Association class III/IV, cardiopulmonary bypass time, and impaired pre-operative renal function were independent predictors of AKI. However, time between coronary angiogram and cardiac surgery was not a predictor (P 0.41). AKI occurred in 35 of 433 patients operated within 3 days of coronary angiogram vs. 31 of 1700 patients operated after 3 days (P 0.17). Results were the same in patients with impaired pre-operative renal function and those with contrast-induced nephropathy. Risk of AKI after cardiac surgery is not influenced by the time between coronary angiogram and cardiac surgery. These results do not support the notion of delaying cardiac surgery for the sole purpose of renal recovery after coronary angiogram.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cardiac & Cardiovascular Systems

Extracranial Systemic Embolic Events in Patients With Nonvalvular Atrial Fibrillation Incidence, Risk Factors, and Outcomes

Wobo Bekwelem, Stuart J. Connolly, Jonathan L. Halperin, Selcuk Adabag, Sue Duval, Susan Chrolavicius, Janice Pogue, Michael D. Ezekowitz, John W. Eikelboom, Lars G. Wallentin, Salim Yusuf, Alan T. Hirsch

CIRCULATION (2015)

Article Cardiac & Cardiovascular Systems

Can Autocapture Function of Permanent Pacemakers Initiate Ventricular Tachyarrhythmias?

Baris Akdemir, Kairav Vakil, David Benditt, Selcuk Adabag

PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY (2016)

Article Cardiac & Cardiovascular Systems

Obesity related risk of sudden cardiac death in the atherosclerosis risk in communities study

Selcuk Adabag, Rachel R. Huxley, Faye L. Lopez, Lin Y. Chen, Nona Sotoodehnia, David Siscovick, Rajat Deo, Suma Konety, Alvaro Alonso, Aaron R. Folsom

HEART (2015)

Article Cardiac & Cardiovascular Systems

Impact of defibrillation threshold testing on burden of heart failure hospitalizations

Baris Akdemir, Yanhui Li, Balaji Krishnan, Selcuk Adabag, Venkatakrishna Tholakanahalli, David G. Benditt, Jian-Ming Li

ACTA CARDIOLOGICA (2020)

Article Cardiac & Cardiovascular Systems

Sudden cardiac death risk prediction in heart failure with preserved ejection fraction

Selcuk Adabag, Lisa Langsetmo

HEART RHYTHM (2020)

Article Cardiac & Cardiovascular Systems

Effects of hydroxychloroquine treatment on QT interval

Matthew Hooks, Bradley Bart, Orly Vardeny, Anders Westanmo, Selcuk Adabag

HEART RHYTHM (2020)

Article Cardiac & Cardiovascular Systems

Nonsustained ventricular tachycardia in heart failure with preserved ejection fraction

Alejandra Gutierrez, Jerry Ash, Baris Akdemir, Tamas Alexy, Rebecca Cogswell, Jane Chen, Selcuk Adabag

PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY (2020)

Article Cardiac & Cardiovascular Systems

Trajectory of left ventricular ejection fraction among individuals eligible for implantable cardioverter-defibrillator

Selma Carlson, Amy Gravely, Selcuk Adabag

Summary: Among patients eligible for ICD therapy, there is significant fluctuation in left ventricular ejection fraction (EF), with some patients experiencing improvement followed by subsequent decline. Patients with nonischemic cardiomyopathy were more likely to have EF improvement to >35% at first follow-up compared to those with ischemic cardiomyopathy.

PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY (2021)

Editorial Material Cardiac & Cardiovascular Systems

An attempt to reconcile the contrasting results of analyses on implantable cardioverter-defibrillator shocks during the pandemic

Selcuk Adabag, Mohammad Madjid, Alan Cheng

EUROPEAN HEART JOURNAL (2022)

Article Cardiac & Cardiovascular Systems

Predictors of Sudden Cardiac Arrest Among Patients With Post-Myocardial Infarction Ejection Fraction Greater Than 35%

Selcuk Adabag, Patrick Zimmerman, Daniel Lexcen, Alan Cheng

Summary: Patients with a post-MI EF >35% have a substantial annual risk of SCA, with factors such as lack of revascularization, post-MI EF <50%, Black race, renal failure, chronic obstructive pulmonary disease, antiarrhythmic therapy, and absence of beta blocker therapy predicting higher risk. Identifying high-risk patients using a multivariable risk model can help in further risk assessment and monitoring to prevent SCA.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2021)

Article Cardiac & Cardiovascular Systems

Implantable Cardioverter-Defibrillator Shocks During COVID-19 Outbreak

Selcuk Adabag, Patrick Zimmerman, Adam Black, Mohammad Madjid, Payam Safavi-Naeini, Alan Cheng

Summary: An increase in defibrillator shock episodes was observed in New York City, New Orleans, and Boston during the surge of COVID-19 activity, especially among patients who had experienced one or more shocks previously. However, the likelihood of any given patient having a shock episode did not differ between 2020 and 2019.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2021)

Article Cardiac & Cardiovascular Systems

Improvement of left ventricular function with surgical revascularization in patients eligible for implantable cardioverter-defibrillator

Selcuk Adabag, Selma Carlson, Amy Gravely, Melissa Buelt-Gebhardt, Mohammad Madjid, Niyada Naksuk

Summary: One-third of ICD-eligible patients undergoing CABG show significant improvement in EF, reducing the need for primary prevention ICD implantation. EF improvement is associated with lower risks of all-cause mortality and heart failure mortality.

JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2022)

Editorial Material Cardiac & Cardiovascular Systems

To replace or not to replace: What to do with the implantable cardioverter-defibrillator generator when the left ventricular function has improved

Selcuk Adabag, Scott Hubers

JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2023)

Article Cardiac & Cardiovascular Systems

Mortality associated with antiarrhythmic medication for atrial fibrillation among patients with left ventricular hypertrophy

Arianne Clare Agdamag, Anders Westanmo, Amy Gravely, Natthapon Angsubhakorn, Lin Yee Chen, Selcuk Adabag

Summary: This study retrospectively analyzed the medical records of 8204 atrial fibrillation patients who were prescribed antiarrhythmic medications. It found that among patients with left ventricular hypertrophy, amiodarone use was associated with a higher risk of mortality compared to other antiarrhythmic medications.

PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY (2023)

Letter Cardiac & Cardiovascular Systems

Reply to the Editor - Are we close to a major impact on prevention of sudden cardiac death among coronary artery disease patients

Michael C. Downey, Matthew Hooks, Selcuk Adabag

HEART RHYTHM O2 (2022)

No Data Available